BioSpace News Archive

Biotech Bay

Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines

Septerna, a biotechnology company discovering and advancing novel oral small molecule medicines targeting G protein-coupled receptors, announced the closing of a $150 million Series B financing.

July 11, 2023
·
5 min read
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration

Silence Therapeutics plc announced that it will receive a $4.0 million cash payment from Hansoh Pharmaceutical Group Company Limited following the achievement of two undisclosed preclinical milestones.

July 11, 2023
·
4 min read
Business

Verastem Oncology Announces Promotion of Dan Paterson to Chief Executive Officer

Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that Dan Paterson, President and Chief Operating Officer, has been promoted to President and Chief Executive Officer (CEO).

July 11, 2023
·
8 min read
Genetown

Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer

Crossbow Therapeutics, Inc. today announced an $80 million Series A funding round led by MPM BioImpact and Pfizer Ventures, with participation from Polaris Partners, BVF Partners, Eli Lilly and Company, Mirae Asset Venture Investment, and Mirae Asset Capital.

July 11, 2023
·
3 min read
Biotech Beach

FIRST SURGICAL PROCEDURES IN THE WORLD USING TETROUS ENFIX RC™ FIBER IMPLANT TO ENHANCE ROTATOR CUFF REPAIR PERFORMED AT RUSH OAK BROOK SURGERY CENTER

Tetrous Inc., a leading regenerative medicine company today announced that it has completed the first four surgical cases using EnFix RC, a procedure-specific implant for rotator cuff repair that is specifically designed to address Enthesis Failure Syndrome.

July 11, 2023
·
3 min read
Drug Development

Soligenix Announces Expansion of SGX302 (Synthetic Hypericin) Phase 2a Study in Mild-to-Moderate Psoriasis

Soligenix, Inc. announced today the expansion of its Phase 2a trial of SGX302 (synthetic hypericin) for the treatment of mild-to-moderate psoriasis after demonstration of biological effect in the initial five subjects.

July 11, 2023
·
12 min read
Biotech Beach

Capsida Biotherapeutics Announces Publication in Nature Nanotechnology Identifying Novel Capsid With Significantly Increased Brain Transduction

Capsida Biotherapeutics (“Capsida”) today announced research published in Nature Nanotechnology describing an adeno-associated virus (AAV) variant that can more effectively transduce the brain in non-human primates (NHPs) than AAV9.

July 11, 2023
·
3 min read
Pluribus Company TeleMED Diagnostic Management Launches 10th Deployment of Proprietary Echo Review and Reporting Module

TeleMED Diagnostic Management Inc. has announced its tenth deployment of its new ViTELflo module for reviewing and reporting Echocardiography and Stress Echocardiography studies.

July 11, 2023
·
6 min read
Business

The Pancreatic Cancer Action Network (PANCAN) Welcomes Four New Leaders to Its Distiguished Board of Directors

The Pancreatic Cancer Action Network, a leading nonprofit in the fight against pancreatic cancer, proudly announces the addition of four esteemed business leaders, Jay T. Backstrom, MD, MPH, Rich Hume, Eric Park and Mace Rothenberg, MD, to its national board of directors.

July 11, 2023
·
6 min read
Biotech Beach

TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma

TRACON Pharmaceuticals announced it has collected the previously announced arbitration award from I-Mab Biopharma.

July 11, 2023
·
5 min read